International Clinical Trial: A Phase IV Study to Evaluate the Immune Responses of Subunit Influenza Vaccine in Healthy Adults

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854392) titled 'A Phase IV Study to Evaluate the Immune Responses of Subunit Influenza Vaccine in Healthy Adults' on Sept. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: Ab&B Bio-tech Co., Ltd.JS

Condition: Influenza

Intervention: Biological: Group A

Recruitment Status: Recruiting

Phase: Phase 4

Date of First Enrollment: October 11, 2026

Target Sample Size: 138

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07854392

Disclaimer: Curated by HT ...